[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"detail-sidebar-cat-0-en-105":3,"doc-seo-346377-105":59,"doc-detail-346377-en":131},{"code":4,"msg":5,"data":6},0,"success",[7,13,18,23,28,33,38,43,48,51,55],{"id":8,"doc_module":4,"doc_module_name":9,"category_name":10,"show_sort_weight":11,"slug":12},1,"Document","Story & Novel",90,"story-novel",{"id":14,"doc_module":4,"doc_module_name":9,"category_name":15,"show_sort_weight":16,"slug":17},2,"Literature",80,"literature",{"id":19,"doc_module":4,"doc_module_name":9,"category_name":20,"show_sort_weight":21,"slug":22},4,"Exam",70,"exam",{"id":24,"doc_module":4,"doc_module_name":9,"category_name":25,"show_sort_weight":26,"slug":27},5,"Comic",60,"comic",{"id":29,"doc_module":4,"doc_module_name":9,"category_name":30,"show_sort_weight":31,"slug":32},6,"Technology",50,"technology",{"id":34,"doc_module":4,"doc_module_name":9,"category_name":35,"show_sort_weight":36,"slug":37},7,"Healthcare",40,"healthcare",{"id":39,"doc_module":4,"doc_module_name":9,"category_name":40,"show_sort_weight":41,"slug":42},8,"Research & Report",30,"research-report",{"id":44,"doc_module":4,"doc_module_name":9,"category_name":45,"show_sort_weight":46,"slug":47},9,"Religion & Spirituality",20,"religion-spirituality",{"id":46,"doc_module":4,"doc_module_name":9,"category_name":49,"show_sort_weight":46,"slug":50},"World Cup","world-cup",{"id":52,"doc_module":4,"doc_module_name":9,"category_name":53,"show_sort_weight":52,"slug":54},10,"Lifestyle","lifestyle",{"id":56,"doc_module":4,"doc_module_name":9,"category_name":57,"show_sort_weight":24,"slug":58},19,"General","general",{"code":4,"msg":60,"data":61},"ok",{"site_id":62,"language":63,"slug":64,"title":65,"keywords":66,"description":67,"schema_data":68,"social_meta":124,"head_meta":126,"extra_data":128,"updated_unix":130},105,"en","prognostic-heterogeneity-of-hpv-associated-oropharyngeal-cancer-in-a-taiwanese-population","Prognostic heterogeneity of HPV-associated oropharyngeal cancer in a Taiwanese population","","Background Oropharyngeal squamous cell carcinoma (OPSCC) is rising globally and is linked to human papillomavirus (HPV), but it remains unclear how lifestyle risk factors—especially smoking, alcohol use, and betel-quid chewing—alter prognosis in HPV-associated disease. Evidence is particularly limited in high-exposure regions such as Taiwan, where viral and behavioral determinants may interact. Methods used data from the Taiwan Cancer Registry to assess survival patterns by p16 status and lifestyle exposures. Results 23.2% of cases were p16-positive, with higher positivity in females and tonsillar subsites. While p16-positive patients showed superior 5-year overall survival, multiple lifestyle risks substantially reduced this benefit, and gradients persisted after adjustment. In p16-negative disease, lifestyle factors were not independently associated with survival. Conclusions The prognostic advantage of p16 positivity is attenuated by accumulating lifestyle risks, supporting integrated viral-behavioral prognostic assessment.",{"@graph":69,"@context":123},[70,84,106],{"@type":71,"itemListElement":72},"BreadcrumbList",[73,77,79,82],{"item":74,"name":75,"@type":76,"position":8},"https://docshare.wps.com","Home","ListItem",{"item":78,"name":9,"@type":76,"position":14},"https://docshare.wps.com/document/",{"item":80,"name":40,"@type":76,"position":81},"https://docshare.wps.com/document/research-report/",3,{"item":83,"name":65,"@type":76,"position":19},"https://docshare.wps.com/document/prognostic-heterogeneity-of-hpv-associated-oropharyngeal-cancer-in-a-taiwanese-population/346377/",{"url":83,"name":65,"@type":85,"image":86,"author":91,"headline":65,"publisher":94,"fileFormat":97,"inLanguage":63,"description":67,"dateModified":98,"datePublished":99,"encodingFormat":97,"isAccessibleForFree":100,"interactionStatistic":101},"DigitalDocument",{"url":87,"@type":88,"width":89,"height":90},"https://docshare.wps.com/thumbnails/prognostic-heterogeneity-of-hpv-associated-oropharyngeal-cancer-in-a-taiwanese-population/346377.png","ImageObject",300,407,{"name":92,"@type":93},"Patrick","Person",{"url":74,"name":95,"@type":96},"DocShare","Organization","application/pdf","2026-11-03","2026-09-22",true,{"@type":102,"interactionType":103,"userInteractionCount":105},"InteractionCounter",{"@type":104},"ViewAction",14,{"@type":107,"mainEntity":108},"FAQPage",[109,115,119],{"name":110,"@type":111,"acceptedAnswer":112},"How was HPV infection assessed in this study?","Question",{"text":113,"@type":114},"HPV infection was inferred using p16 status as a surrogate marker.","Answer",{"name":116,"@type":111,"acceptedAnswer":117},"What data and time period were used for the retrospective cohort study?",{"text":118,"@type":114},"The study retrospectively analyzed 5,671 OPSCC patients using Taiwan Cancer Registry data collected between 2018 and 2021.",{"name":120,"@type":111,"acceptedAnswer":121},"What was the key finding about survival in p16-positive vs p16-negative patients?",{"text":122,"@type":114},"p16-positive patients had significantly better 5-year overall survival than p16-negative patients, but the advantage in p16-positive individuals was markedly reduced when multiple lifestyle risk factors were present.","https://schema.org",{"og:url":83,"og:type":125,"og:title":65,"og:site_name":95,"og:description":67},"article",{"robots":127,"canonical":83},"index,follow",{"doc_id":129,"site_id":62},346377,1790177177,{"code":4,"msg":5,"data":132},{"doc_id":129,"user_id":133,"nickname":92,"user_avatar":134,"doc_module":4,"category_id":39,"category_name":40,"doc_title":65,"doc_description":67,"doc_content":135,"file_id":136,"file_url":137,"file_type":138,"file_size":139,"view_count":105,"is_deleted":4,"is_public":8,"is_downloadable":8,"audit_status":8,"page_count":140,"language":141,"language_code":63,"site_id":62,"html_lang":63,"table_of_contents":142,"faqs":143,"seo_title":144,"seo_description":67,"update_tm":145,"read_time":146,"preview_page_count":19,"preview_urls":147},549758146520,"https://ap-avatar.wpscdn.com/avatar/80002397d8c0411e94?_k=1775819394049821470","Liu et al. BMC Cancer (2026) 26:179 BMC Cancer  \n[https://doi.org/10.1186/s12885-025-15528-4](https://doi.org/10.1186/s12885-025-15528-4)  \nRESEARCH Open Access  \nPrognostic heterogeneity of HPV-associated oropharyngeal cancer in a Taiwanese population  \nPeng-Tzu Liu 1,2,3,4†, Chun-Ju Chiang5,6†, Ya-Wen Yang6,7, Wen-Chung Lee5,6,7, Wan-Lun Hsu8,9, Tzu-I Chen9,  \nHui-Ling Lee10, Cheng-Ping Wang11, Li-Jen Liao 12, Chia-Chuan Wang3, Vinchi Wang3,13* and Yong-Chen Chen9,14*  \nAbstract  \nBackground Oropharyngeal squamous cell carcinoma (OPSCC) is increasing worldwide, with a well-established link to human papillomavirus (HPV) . However, evidence on how lifestyle risk factors—particularly smoking, alcohol consumption, and betel-quid chewing—modify the prognostic impact of HPV-associated disease remains limited, especially in regions with high exposure burden such as Taiwan. Understanding the interplay between viral and lifestyle determinants is essential for accurate prognostication and treatment planning.  \nMethods We conducted a retrospective cohort study of 5,671 OPSCC patients using data from the Taiwan Cancer Registry between 2018 and 2021. p16 status was used as a surrogate marker for HPV infection. Overall survival and cancer-specific survival were compared across p16 status, age, sex, tumor location, cancer stage, lifestyle risk factors and treatment pattern using Kaplan–Meier method and multiple Cox models. Treatment-stratified analyses were additionally performed to evaluate whether lifestyle risk factors modified prognosis within p16-positive disease. Results Overall, 23 . 2% of OPSCC cases were p16-positive, with substantially higher p16 positivity among females (52 . 5%) and in tonsillar subsites. p16-positive patients had significantly better 5-year overall survival (69 . 0%; 95% CI, 66 . 0%-71 . 8%) than p16-negative patients (37 . 9%; 36 . 1%-39 . 6%) . However, among p16-positive individuals, the presence of multiple lifestyle risk factors markedly attenuated the survival advantage, reducing 5-year overall survival from 78. 6%(74 . 0%-82 . 5%) in those without lifestyle exposures to 57 . 6%(52 . 6%-62 .4%) in those with smoking plus other risks. These gradients persisted after multivariable adjustment and across treatment modalities. In contrast, lifestyle risk factors were not independently associated with survival in p16-negative OPSCC, where prognosis was primarily driven by tumor stage, subsite, and treatment.  \nConclusions This nationwide study provides novel evidence that the prognostic benefit associated with p16 positivity is substantially attenuated by multiple lifestyle risk factors. These findings highlight the importance of integrating viral and behavioral determinants into prognostic assessment and treatment planning. They also  \n†Peng-Tzu Liu and Chun-Ju Chiang contributed equally to this work.  \n*Correspondence: Vinchi Wang [vwneur@yahoo.com.tw](vwneur@yahoo.com.tw)[ ](vwneur@yahoo.com.tw)Yong-Chen Chen [137159@mail.fju.edu.tw](137159@mail.fju.edu.tw)  \nFull list of author information is available at the end of the article  \n© The Author(s) 2026. Open Access This article is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License, which permits any non-commercial use, sharing, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if you modified the licensed material. You do not have permission under this licence to share adapted material derived from this article or parts of it. The images or other third party material in this article are included in the article’s Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will","cbCaicldbhia2xtz","https://ap.wps.com/l/cbCaicldbhia2xtz","pdf",2418324,13,"English","# Abstract\n# Background\n# Methods\n# Results\n# Conclusions\n# Keywords\n# Introduction","[{\"question\":\"How was HPV infection assessed in this study?\",\"answer\":\"HPV infection was inferred using p16 status as a surrogate marker.\"},{\"question\":\"What data and time period were used for the retrospective cohort study?\",\"answer\":\"The study retrospectively analyzed 5,671 OPSCC patients using Taiwan Cancer Registry data collected between 2018 and 2021.\"},{\"question\":\"What was the key finding about survival in p16-positive vs p16-negative patients?\",\"answer\":\"p16-positive patients had significantly better 5-year overall survival than p16-negative patients, but the advantage in p16-positive individuals was markedly reduced when multiple lifestyle risk factors were present.\"}]","Prognostic heterogeneity of HPV-associated oropharyngeal cancer in a Taiwanese population | PDF",1790061172,33,[148,152,156,160],{"page_no":8,"url":149,"width":150,"height":151},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/043fbf44b9fb7c9f4eda05e55db371db.webp",983,1310,{"page_no":14,"url":153,"width":154,"height":155},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/2142d390011426bac24a5c859e686a6b.webp",982,1309,{"page_no":81,"url":157,"width":158,"height":159},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/1621fed8e4fedfd1c342a8a469f7235b.webp",981,1308,{"page_no":19,"url":161,"width":162,"height":163},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/9f07ef4d7c94658fd4a65945d33a4164.webp",980,1306]